Abstract
1. There seems no reason why clinical pharmacology studies conducted within the pharmaceutical industry should be exempt from the requirement of ethical review, and independent review in this situation reduces the vulnerability of the company and its employees, in addition to serving its primary function of protecting the volunteer subjects. 2. Experience within one company has shown that independent ethical review need not seriously influence the pace of research. 3. It is important that such committees should be seen to be independent and competent.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eilenberg M. D., Williams R., Witts L. J. New horizons in medical ethics. Research investigations in adults. Br Med J. 1973 Apr 28;2(5860):220–224. doi: 10.1136/bmj.2.5860.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansch C., Dunn W. J., 3rd Linear relationships between lipophilic character and biological activity of drugs. J Pharm Sci. 1972 Jan;61(1):1–19. doi: 10.1002/jps.2600610102. [DOI] [PubMed] [Google Scholar]